A wrongful death lawsuit was filed in federal court over a blood thinning medication. <\/p>\n
The lawsuit was filed against a number of corporations that are part of Bayer Corporation and Johnson & Johnson, the marketers and manufacturers of Xarelto, a blood thinner, on behalf of the family of a man who died in 2013 after a bleeding event allegedly caused by Xarelto. <\/p>\n
Xarelto was approved by the FDA for sale in the U.S. in 2011. It is the second in a new class of anticoagulants to be approved, after Pradaxa, which was approved in 2010. The new drugs are marketed as an improvement over warfarin or Coumadin, which is often used in stroke prevention, but may disrupt vitamin K levels and requires frequent blood testing. <\/p>\n
In late 2014, litigants sought to establish a multidistrict litigation (MDL) for Xarelto cases. Most plaintiffs requested that the MDL be established under Judge Herndon (more…)<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":" A wrongful death lawsuit was filed in federal court over a blood thinning medication. The lawsuit was filed against a number of corporations that are part of Bayer Corporation and Johnson & Johnson, the marketers and manufacturers of Xarelto, a…<\/span><\/p>\n